Evolution of Procalcitonin and Thyroid Hormones in Patients with Renal Failure in Alkarama Teaching Hospital, Iraq
Israa University Journal for Applied Science · 25.02.2026 · 9 (special issue) · 1-9
DOI: 10.52865/jdpq6193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Israa University Journal for Applied Science, online erschienen am 25.02.2026. Verfasst von Zaid A. Al-Tayef und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Renal failure is one of the common diseases in the modern era, especially recently, while thyroid hormones are considered to have an effect on all body functions such as the heart, muscles, and brain, and they also have an effect on kidney functions. Aims of the study: The current study aimed to measure and compare selected physiological and biochemical parameters in patients with renal failure.
Methods
Study samples were collected from private clinics in Samarra and from the Dialysis Center at Al-Karama Teaching Hospital, Baghdad. A total of 105 blood samples were collected and divided into three groups: pre-dialysis patients (n = 40), post-dialysis patients (n = 40), and a healthy control group (n = 25). The participants’ ages ranged from 25 to 60 years, and all participants were male.
Results
The results demonstrated significant differences in procalcitonin levels (pg/mL) among patients with renal failure. Procalcitonin was significantly elevated in the pre-dialysis group (2802.13 ± 812.56 pg/mL) and decreased after dialysis (1042.21 ± 224.60 pg/mL) compared with the control group (979.92 ± 312.45 pg/mL). In addition, endothelin levels (pg/mL) showed statistically significant reduction in both the pre-dialysis group (60.26 ± 19.20 pg/mL) and the post-dialysis group (58.34 ± 18.65 pg/mL) when compared with the control group (220.98 ± 70.62 pg/mL). Regarding thyroid hormones, there was a significant reduction in serum triiodothyronine (T3) and thyroxine (T4) levels in patients with renal failure compared with the control. Mean T3 values were (1.16 ± 0.30 ng/mL) in pre-dialysis and (1.15 ± 0.30 ng/mL) in post-dialysis, while T4 values were (67.62 ± 14.57 nmol/L) in pre-dialysis and (66.04 ± 13.45 nmol/L) in post-dialysis, compared with the control group (T3: 2.15 ± 0.49 ng/mL, T4: 99.90 ± 22.78 nmol/L). No statistically significant differences were observed in thyroid-stimulating hormone (TSH, µIU/mL) levels.
Conclusion
These findings indicate that renal failure and hemodialysis significantly influence procalcitonin and thyroid hormone levels, while TSH levels remain relatively stable.
Zitieren
APA
Al-Tayef, Z. A., & Hassan, Z. L. (2026). Evolution of Procalcitonin and Thyroid Hormones in Patients with Renal Failure in Alkarama Teaching Hospital, Iraq. Israa University Journal for Applied Science, 9(special issue), 1-9. https://doi.org/10.52865/jdpq6193
Vancouver
Al-Tayef ZA, Hassan ZL. Evolution of Procalcitonin and Thyroid Hormones in Patients with Renal Failure in Alkarama Teaching Hospital, Iraq. Israa University Journal for Applied Science. 2026;9(special issue):1-9. doi:10.52865/jdpq6193
BibTeX
@article{AlTayef2026,
author = {Al-Tayef, Zaid A. and Hassan, Zina L.},
title = {Evolution of Procalcitonin and Thyroid Hormones in Patients with Renal Failure in Alkarama Teaching Hospital, Iraq},
journal = {Israa University Journal for Applied Science},
year = {2026},
volume = {9},
number = {special issue},
pages = {1--9},
doi = {10.52865/jdpq6193}
}
EUVIMED